# Does MOTS-c reduce inflammaging in older adults?

Canonical source: https://retacompare.com/research/does-mots-c-reduce-inflammaging-in-older-adults

Peptide Longevity Q&A · 2026-03-01


    Research indicates that mitochondrial-derived microproteins, particularly MOTS-c, may play a role in combating inflammaging, especially in the context of various diseases. These microproteins have shown alterations in disease states associated with aging, suggesting their potential significance in inflammatory processes.

 What the research shows

The review article focuses on mitochondrial-derived microproteins (MDPs), especially MOTS-c, and their implications in lung diseases and other age-related conditions. MDPs are encoded within small open reading frames of mitochondrial DNA and are known to be altered in various disease states. The study highlights the need for further exploration of MDPs in lung homeostasis and diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and acute lung injury. The review emphasizes that while most research has centered on the effects of MOTS-c and Humanin in tissues with high mitochondrial density (like the heart and brain), their roles in lung health and inflammation are less understood.

 Why it matters for longevity

Understanding the role of MOTS-c in combating inflammaging is crucial for longevity research. Inflammaging refers to the chronic, low-grade inflammation that often accompanies aging and can contribute to various age-related diseases. By investigating how MDPs like MOTS-c influence inflammatory processes, researchers may uncover new therapeutic avenues to enhance healthspan and mitigate age-associated ailments. The potential for MDPs to act on both mitochondrial and nuclear pathways suggests a multifaceted approach to managing inflammation and promoting longevity.

 Key findings at a glance

MOTS-c is a mitochondrial-derived microprotein implicated in various disease states.

Research has primarily focused on MOTS-c in tissues with high mitochondrial density.

MDPs may play a role in lung diseases such as COPD and pulmonary fibrosis.

There is a recognized gap in understanding the role of MDPs in lung homeostasis.

Further investigation into MDPs could reveal their therapeutic potential for inflammatory diseases.

 How MOTS-c works (background)

MOTS-c is a bioactive microprotein derived from mitochondrial DNA, which plays a role in various cellular processes. It is believed to exert effects on mitochondrial function, energy metabolism, and cellular stress responses. In the context of aging, MOTS-c may help modulate inflammatory responses and improve mitochondrial health, potentially counteracting the detrimental effects of chronic inflammation associated with aging. This microprotein's ability to influence both mitochondrial and nuclear functions positions it as a potential target for therapies aimed at enhancing longevity and reducing age-related diseases.

 Safety, caveats, and what we don't yet know

While the review highlights the potential roles of MOTS-c in lung health and inflammation, it also points out significant knowledge gaps. Most studies have concentrated on tissues with high mitochondrial density, leaving the specific actions of MOTS-c in lung tissue and its long-term safety in older adults largely unexplored. Further research is needed to clarify the mechanisms by which MOTS-c operates and to assess its efficacy and safety in diverse populations, particularly in older adults who may benefit from interventions targeting inflammaging.

 Bottom line

Research suggests that MOTS-c may have a role in reducing inflammaging, particularly in the context of age-related diseases. However, further investigation is necessary to fully understand its mechanisms and therapeutic potential.

 Related questions

 Can MOTS-c support mitochondrial function in aging muscle tissue?

Research indicates that MOTS-c may enhance mitochondrial function, particularly in tissues like muscle, which are critical for maintaining physical health during aging. Its role in energy metabolism could be significant for older adults.

 What is the relationship between MOTS-c and chronic obstructive pulmonary disease?

MOTS-c has been implicated in various lung diseases, including chronic obstructive pulmonary disease (COPD). Understanding its role could lead to new therapeutic strategies for managing COPD and improving lung health.

 How does MOTS-c interact with the NAD+ pathway?

While the specific interactions between MOTS-c and the NAD+ pathway are not detailed in the source, research suggests that mitochondrial function, which MOTS-c influences, is closely linked to NAD+ metabolism, potentially impacting energy production and cellular health.

 Source: PubMed · Am J Physiol Lung Cell Mol Physiol · published 2026-03-01.

## Sources

- PubMed · Am J Physiol Lung Cell Mol Physiol: https://pubmed.ncbi.nlm.nih.gov/41569667/